Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 1;112(10):979-988.
doi: 10.1093/jnci/djaa050.

A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative Data

Affiliations

A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative Data

Hava Izci et al. J Natl Cancer Inst. .

Abstract

Background: Exact numbers of breast cancer recurrences are currently unknown at the population level, because they are challenging to actively collect. Previously, real-world data such as administrative claims have been used within expert- or data-driven (machine learning) algorithms for estimating cancer recurrence. We present the first systematic review and meta-analysis, to our knowledge, of publications estimating breast cancer recurrence at the population level using algorithms based on administrative data.

Methods: The systematic literature search followed Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. We evaluated and compared sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy of algorithms. A random-effects meta-analysis was performed using a generalized linear mixed model to obtain a pooled estimate of accuracy.

Results: Seventeen articles met the inclusion criteria. Most articles used information from medical files as the gold standard, defined as any recurrence. Two studies included bone metastases only in the definition of recurrence. Fewer studies used a model-based approach (decision trees or logistic regression) (41.2%) compared with studies using detection rules without specified model (58.8%). The generalized linear mixed model for all recurrence types reported an accuracy of 92.2% (95% confidence interval = 88.4% to 94.8%).

Conclusions: Publications reporting algorithms for detecting breast cancer recurrence are limited in number and heterogeneous. A thorough analysis of the existing algorithms demonstrated the need for more standardization and validation. The meta-analysis reported a high accuracy overall, which indicates algorithms as promising tools to identify breast cancer recurrence at the population level. The rule-based approach combined with emerging machine learning algorithms could be interesting to explore in the future.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PRISMA or Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram for the identification, screening, and inclusion of research articles for the systematic review. Last search conducted on July 16, 2019. *Wrong publication type (meeting abstract, book): n = 23; wrong outcome (prediction of breast cancer recurrence, detection of incident breast cancer or treatment outcome): n = 23; no performance measures: n = 3; no administrative claims: n = 3; foreign language (non-English): n = 1.
Figure 2.
Figure 2.
Distribution of included studies by publication year. In the last 10 years, more articles were published on the topic of detection of breast cancer recurrence using administrative data.
Figure 3.
Figure 3.
Definitions of sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy in the context of algorithms for detection of recurrences. FN = false negative; FP = false positive; TN = true negative; TP = true positive.

References

    1. IARC. Cancer fact sheets. Global Cancer Observatory - IARC. https://gco.iarc.fr/today/fact-sheets-cancers. Accessed September 5, 2019.
    1. Kaiser K, Cameron KA, Beaumont J, et al. What does risk of future cancer mean to breast cancer patients? Breast Cancer Res Treat. 2019;175(3):579–584. - PMC - PubMed
    1. In H, Bilimoria KY, Stewart AK, et al. Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014;21(5):1520–1529. doi: 10.1245/s10434-014-3516-x. - PubMed
    1. Warren JL, Yabroff KR. Challenges and opportunities in measuring cancer recurrence in the United States. J Natl Cancer Inst. 2015;107(8); doi: 10.1093/jnci/djv134. - PMC - PubMed
    1. Kroenke CH, Chubak J, Johnson L, Castillo A, Weltzien E, Caan BJ. Enhancing breast cancer recurrence algorithms through selective use of medical record data. J Natl Cancer Inst. 2016;108(3); doi: 10.1093/jnci/djv336. - PMC - PubMed

Publication types

MeSH terms